DSKYF (Daiichinkyo Co) Piotroski F-Score: 4 (As of Jun. 25, 2026) — 43% Below Median


DSKYF Daiichi Sankyo Co Ltd DSKYF
73 GF Score
Price $14.76
GF Value $40.31
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Daiichinkyo Co Piotroski F-Score?

Daiichinkyo Co DSKYF -4.91% 73 Piotroski F-Score is 4 as of Jun. 25, 2026, which is 43% below its 10-year median of 7.00. GuruFocus rates DSKYF with a GF Score™ of 73/100 and a GF Value™ of $40.31 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 981 Drug Manufacturers companies, Daiichinkyo Co ranks worse than 60.86% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Daiichinkyo Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Daiichinkyo Co's Piotroski F-Score or its related term are showing as below:

DSKYF' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 7   Max: 8
Current: 4

During the past 13 years, the highest Piotroski F-Score of Daiichinkyo Co was 8. The lowest was 4. And the median was 7.

Daiichinkyo Co  (OTCPK:DSKYF) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Daiichinkyo Co Piotroski F-Score Related Terms


Daiichinkyo Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Daiichinkyo Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daiichinkyo Co Piotroski F-Score Chart

Daiichinkyo Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 7.00 8.00 6.00 4.00

Daiichinkyo Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 N/A 5.00 6.00 4.00

DSKYF vs LLY, JNJ, ABBV: Piotroski F-Score Comparison

For the Drug Manufacturers - General subindustry, Daiichinkyo Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daiichinkyo Co Piotroski F-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Daiichinkyo Co's Piotroski F-Score falls into.


DSKYF
73GF Score
Daiichi Sankyo Co Ltd DSKYF
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 591.763 + 306.46 + 555.636 + 267.376 = $1,721 Mil.
Cash Flow from Operations was -253.088 + 55.836 + 513.459 + 163.282 = $479 Mil.
Revenue was 3284.783 + 3386.624 + 3579.553 + 3715.503 = $13,966 Mil.
Gross Profit was 2645.631 + 2331.728 + 2820.941 + 1809.567 = $9,608 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(23186.466 + 23944.72 + 24139.192 + 24512.144 + 25241.504) / 5 = $24204.8052 Mil.
Total Assets at the begining of this year (Mar25) was $23,186 Mil.
Long-Term Debt & Capital Lease Obligation was $1,891 Mil.
Total Current Assets was $13,502 Mil.
Total Current Liabilities was $5,577 Mil.
Net Income was 540.878 + 428.753 + 402.615 + 584.693 = $1,957 Mil.

Revenue was 2763.05 + 3123.746 + 3152.113 + 3479.789 = $12,519 Mil.
Gross Profit was 2160.934 + 2438.022 + 2317.45 + 2846.893 = $9,763 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(23102.172 + 0 + 23064.265 + 22388.113 + 23186.466) / 5 = $22935.254 Mil.
Total Assets at the begining of last year (Mar24) was $23,102 Mil.
Long-Term Debt & Capital Lease Obligation was $677 Mil.
Total Current Assets was $12,810 Mil.
Total Current Liabilities was $5,059 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Daiichinkyo Co's current Net Income (TTM) was 1,721. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Daiichinkyo Co's current Cash Flow from Operations (TTM) was 479. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=1721.235/23186.466
=0.07423447

ROA (Last Year)=Net Income/Total Assets (Mar24)
=1956.939/23102.172
=0.08470801

Daiichinkyo Co's return on assets of this year was 0.07423447. Daiichinkyo Co's return on assets of last year was 0.08470801. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Daiichinkyo Co's current Net Income (TTM) was 1,721. Daiichinkyo Co's current Cash Flow from Operations (TTM) was 479. ==> 479 <= 1,721 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=1891.051/24204.8052
=0.07812709

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=677.141/22935.254
=0.02952402

Daiichinkyo Co's gearing of this year was 0.07812709. Daiichinkyo Co's gearing of last year was 0.02952402. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=13501.844/5577.312
=2.42085148

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=12810.035/5058.662
=2.53229708

Daiichinkyo Co's current ratio of this year was 2.42085148. Daiichinkyo Co's current ratio of last year was 2.53229708. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Daiichinkyo Co's number of shares in issue this year was 1851.288. Daiichinkyo Co's number of shares in issue last year was 1897.481. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=9607.867/13966.463
=0.68792414

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=9763.299/12518.698
=0.77989732

Daiichinkyo Co's gross margin of this year was 0.68792414. Daiichinkyo Co's gross margin of last year was 0.77989732. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=13966.463/23186.466
=0.60235411

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=12518.698/23102.172
=0.54188403

Daiichinkyo Co's asset turnover of this year was 0.60235411. Daiichinkyo Co's asset turnover of last year was 0.54188403. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+0+0+0+1+0+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Daiichinkyo Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 4 mean?
Daiichinkyo Co (DSKYF) has a Piotroski F-Score of 4 as of Jun. 25, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Daiichinkyo Co and its competitors. This is 43% below median its historical median of 7.00. Over the past decade, Daiichinkyo Co's Piotroski F-Score has ranged from 4.00 to 8.00. According to the industry distribution chart, Daiichinkyo Co ranks #597 out of 981 companies in the Drug Manufacturers industry, placing it in the top 60.9%.
Is Daiichinkyo Co's Piotroski F-Score too high?
Daiichinkyo Co's current Piotroski F-Score of 4 is 43% below median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 8.00. The Drug Manufacturers industry median Piotroski F-Score is 5.00. Daiichinkyo Co's value of 4 is 20% below this industry median. Based on the distribution chart, Daiichinkyo Co ranks #597 out of 981 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Daiichinkyo Co has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Daiichinkyo Co's Piotroski F-Score compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Daiichinkyo Co ranks #597 out of 981 companies for Piotroski F-Score. This places Daiichinkyo Co in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Daiichinkyo Co's value of 4 is 20% below this benchmark. Historically, Daiichinkyo Co's own Piotroski F-Score has ranged from 4.00 to 8.00 over the past decade. While the company's 10-year median is 7.00 vs. the industry median of 5.00, Daiichinkyo Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Drug Manufacturers company?
The median Piotroski F-Score among Drug Manufacturers companies is 5.00, based on 981 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Daiichinkyo Co's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Daiichinkyo Co and its competitors. For the Drug Manufacturers industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Daiichinkyo Co's current Piotroski F-Score is 4, which is 43% below median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiichinkyo Co stock overvalued right now?
Based on GuruFocus' analysis, Daiichinkyo Co (DSKYF) is currently considered Significantly Undervalued. The stock's GF Value™ is $40.31, compared to a current price of $14.76 — trading 63.4% below its estimated fair value. The current Piotroski F-Score is 4, which is 43% below median its 10-year median of 7.00 and 20% below the Drug Manufacturers industry median of 5.00. Daiichinkyo Co's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Daiichinkyo Co (DSKYF), the current Piotroski F-Score is 4 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Daiichinkyo Co (DSKYF) Overvalued in 2026?

Based on GuruFocus' analysis, Daiichinkyo Co stock appears to be undervalued. The current stock price of $14.76 is trading 63.4% below its estimated GF Value™ of $40.31. GuruFocus considers Daiichinkyo Co to be Significantly Undervalued.

Key valuation signals for DSKYF:

  • Piotroski F-Score: 4 (43% below median its 10-year median of 7.00)
  • GF Value™: $40.31 vs. price of $14.76 (63.4% below fair value)
  • GF Score™: 73/100 with 3 warning signs
  • Industry Position: 20% below the Drug Manufacturers median (#597 of 981)

No single metric tells the full story. See the DSKYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Daiichinkyo Co Business Description

Address 3-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8426
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2024, approximately one quarter of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its lead ADCs are Enhertu (HER2), Datroway (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu was first approved in the US in December 2019, and Datroway was first approved in January 2025.
73GF Score

Get the complete analysis for DSKYF

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.76
Price
$40.31
GF Value